Skip to main content
. 2022 Dec 28;16(1):43. doi: 10.3390/ph16010043

Table 5.

% Inhibition values of the most active compound 6j over CDK2, c-Met, FGFR1, VEGFR2, and P38a at 10 µM concentration.

Cpd % Kinase Inhibition at 10 µM
CDK2/cyclin A c-MET FGFR1 KDR/VEGFR2 P38a/MAPK14
6j –0.83 19.27 13.87 10.32 –33.31